Michael Andriole

Track

Insider profile

Currently holds positions in Chimerix Inc and Endocyte Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 58% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Business Officer Chimerix Inc April 4, 2019 -
Chief Financial Officer Endocyte Inc Feb. 20, 2017 -
Michael Andriole's trades of Chimerix Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
19.73
Quantity 74,837 +28.3%
Value US$4,782,901
US Chimerix Inc (CMRX)
Transaction date
Proposed sale
Price
164.44
Quantity 82,935
Value US$2,779,381
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
461.12
Quantity 99,965 +7.6%
Value US$642,651
US Chimerix Inc (CMRX)
Transaction date
Proposed sale
Price
4.00
Quantity 2,500
Value US$10,000
US Chimerix Inc (CMRX)
Transaction date
Proposed sale
Price
0.87
Quantity 1,500
Value US$1,300
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
0.83
Quantity 1,285 -0.3%
Value US$1,065
US Chimerix Inc (CMRX)
Transaction date
Planned sale
Price
1.04
Quantity 1,744 -0.4%
Value US$1,809
US Chimerix Inc (CMRX)
Transaction date
Proposed sale
Price
1.05
Quantity 2,000
Value US$2,100
US Chimerix Inc (CMRX)
Transaction date
Planned purchase
Price
1.14
Quantity 51,700 +16.9%
Value US$59,150
US Chimerix Inc (CMRX)
Transaction date
Planned purchase
Price
1.71
Quantity 15,000 +7.6%
Value US$25,635
US Chimerix Inc (CMRX)
Transaction date
Planned purchase
Price
1.43
Quantity 33,300 +28.6%
Value US$47,522
US Chimerix Inc (CMRX)
Transaction date
Purchase
Price
1.56
Quantity 100,000 +inf%
Value US$156,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-14 2025-02-13
US Chimerix Inc (CMRX)
PlS Planned sale
74,837 +28.3%
19.73
US$4,782,901 		74,837 +28.3% 19.73 US$4,782,901
2025-02-13 2025-02-13
US Chimerix Inc (CMRX)
PrS Proposed sale
82,935
164.44
US$2,779,381 		82,935 164.44 US$2,779,381
2025-01-31 2025-01-30
US Chimerix Inc (CMRX)
PlS Planned sale
99,965 +7.6%
461.12
US$642,651 		99,965 +7.6% 461.12 US$642,651
2025-01-30 2025-01-30
US Chimerix Inc (CMRX)
PrS Proposed sale
2,500
4.00
US$10,000 		2,500 4.00 US$10,000
2024-08-09 2024-08-08
US Chimerix Inc (CMRX)
PrS Proposed sale
1,500
0.87
US$1,300 		1,500 0.87 US$1,300
2024-08-09 2024-08-08
US Chimerix Inc (CMRX)
PlS Planned sale
1,285 -0.3%
0.83
US$1,065 		1,285 -0.3% 0.83 US$1,065
2024-02-16 2024-02-14
US Chimerix Inc (CMRX)
PlS Planned sale
1,744 -0.4%
1.04
US$1,809 		1,744 -0.4% 1.04 US$1,809
2024-02-14 2024-02-14
US Chimerix Inc (CMRX)
PrS Proposed sale
2,000
1.05
US$2,100 		2,000 1.05 US$2,100
2023-05-19 2023-05-18
US Chimerix Inc (CMRX)
PP Planned purchase
51,700 +16.9%
1.14
US$59,150 		51,700 +16.9% 1.14 US$59,150
2022-05-18 2022-05-17
US Chimerix Inc (CMRX)
PP Planned purchase
15,000 +7.6%
1.71
US$25,635 		15,000 +7.6% 1.71 US$25,635
2020-03-17 2020-03-16
US Chimerix Inc (CMRX)
PP Planned purchase
33,300 +28.6%
1.43
US$47,522 		33,300 +28.6% 1.43 US$47,522
2019-11-07 2019-11-06
US Chimerix Inc (CMRX)
B Purchase
100,000 +inf%
1.56
US$156,000 		100,000 +inf% 1.56 US$156,000